Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2023

Aug 3, 2023

284_dirs_2023-08-03_539a1d52-bfb9-4559-89f5-2afeb638e000.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2023-08-02

Reporting Person: Romanelli Joseph (President, Human Health Int?l)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-02 Common Stock S 30 $107.371 Disposed 20569.325 Direct
2023-08-02 Common Stock S 59 $107.371 Disposed 0 Indirect